Investing

Investing Cash Flow

Bristol-Myers Squibb Investing Cash Flow decreased by 259.8% to -$1.70B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 677.2%, from -$219.00M to -$1.70B.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025

How to read this metric

Typically negative for growing companies as they reinvest cash; a positive value suggests the company is liquidating assets faster than it is buying them.

Detailed definition

The aggregate sum of all cash inflows and outflows related to a company's long-term investments and capital assets. It s...

Peer comparison

Mature companies with high cash flow often show large negative values here as they recycle profits into new growth or financial instruments.

Metric ID: cf_net_cash_from_investing

Historical Data

16 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$180.00M-$976.00M$95.00M-$289.00M-$2.08B-$210.00M-$329.00M-$410.00M-$1.35B-$19.62B-$1.32B-$219.00M-$196.00M-$499.00M-$473.00M-$1.70B
QoQ Change-642.2%+109.7%-404.2%-620.1%+89.9%-56.7%-24.6%-228.3%<-999%+93.3%+83.4%+10.5%-154.6%+5.2%-259.8%
YoY Change-260.6%-113.2%-321.1%-13.8%+80.3%<-999%-300.9%+46.6%+85.4%+97.5%+64.1%-677.2%
Range-$19.62B$180.00M
CAGR+82.0%
Avg YoY Growth-879.6%
Median YoY Growth-63.5%

Frequently Asked Questions

What is Bristol-Myers Squibb's investing cash flow?
Bristol-Myers Squibb (BMY) reported investing cash flow of -$1.70B in Q3 2025.
How has Bristol-Myers Squibb's investing cash flow changed year-over-year?
Bristol-Myers Squibb's investing cash flow decreased by 677.2% year-over-year, from -$219.00M to -$1.70B.
What does investing cash flow mean?
The total net change in cash resulting from buying and selling long-term assets and investments.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.